Vivax Elimination With Tafenoquine (VET) Study
NCT06575647
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
1242
Enrollment
OTHER
Sponsor class
Conditions
Malaria
Malaria, Vivax
Plasmodium Vivax
Plasmodium Vivax Malaria
Interventions
DRUG:
Tafenoquine
Sponsor
Shoklo Malaria Research Unit
Collaborators
Mahidol Oxford Tropical Medicine Research Unit